Interdisciplinary Models for Research and Clinical Endeavors in Genomic Medicine: A Scientific Statement From the American Heart Association.
暂无分享,去创建一个
Svati H Shah | Thomas J. Wang | J. Loscalzo | J. Cooke | K. Musunuru | R. Hershberger | M. Russell | J. Ferguson | J. Lee | C. Macrae | P. Arora | K. Hickey | J. Lima | N. Pereira | F. Sheikh | Svati H. Shah | S. Shah
[1] Steven R Houser,et al. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association. , 2018, Circulation. Genomic and precision medicine.
[2] Jeffrey L. Anderson,et al. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial , 2017, JAMA.
[3] Vishnu Mohan,et al. Use of Simulation Based on an Electronic Health Records Environment to Evaluate the Structure and Accuracy of Notes Generated by Medical Scribes: Proof-of-Concept Study , 2017, JMIR medical informatics.
[4] Kaberi Dasgupta,et al. Validity of Health Administrative Database Definitions for Hypertension: A Systematic Review. , 2017, The Canadian journal of cardiology.
[5] M. Fornage,et al. The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction A Scientific Statement From the American Heart Association , 2017, Circulation. Cardiovascular genetics.
[6] S. Gabriel,et al. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease , 2017, The New England journal of medicine.
[7] Tanya M. Teslovich,et al. Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease , 2017, The New England journal of medicine.
[8] D. Rader,et al. Lack of MTTP Activity in Pluripotent Stem Cell-Derived Hepatocytes and Cardiomyocytes Abolishes apoB Secretion and Increases Cell Stress. , 2017, Cell reports.
[9] Davis J. McCarthy,et al. Common genetic variation drives molecular heterogeneity in human iPSCs , 2017, Nature.
[10] D. Rader,et al. A Drug Screen using Human iPSC-Derived Hepatocyte-like Cells Reveals Cardiac Glycosides as a Potential Treatment for Hypercholesterolemia. , 2017, Cell stem cell.
[11] Gaurav Pandey,et al. Analysis of Transcriptional Variability in a Large Human iPSC Library Reveals Genetic and Non-genetic Determinants of Heterogeneity. , 2017, Cell stem cell.
[12] Fabian Grubert,et al. Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers. , 2017, Cell stem cell.
[13] Christopher D. Brown,et al. Large, Diverse Population Cohorts of hiPSCs and Derived Hepatocyte-like Cells Reveal Functional Genetic Variation at Blood Lipid-Associated Loci. , 2017, Cell stem cell.
[14] Bing Ren,et al. Large-Scale Profiling Reveals the Influence of Genetic Variation on Gene Expression in Human Induced Pluripotent Stem Cells. , 2017, Cell stem cell.
[15] J. Danesh,et al. ANGPTL3 Deficiency and Protection Against Coronary Artery Disease. , 2017, Journal of the American College of Cardiology.
[16] O. Fiehn,et al. Potential Impact and Study Considerations of Metabolomics in Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association. , 2017, Circulation. Cardiovascular genetics.
[17] Praveen Shukla,et al. High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells , 2017, Science Translational Medicine.
[18] Johan Sundström,et al. Epigenetic Patterns in Blood Associated With Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results From Genome-Wide Association Studies , 2017, Circulation. Cardiovascular genetics.
[19] Marylyn D. Ritchie,et al. Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study , 2016, Science.
[20] N. Cook,et al. The Pooled Cohort Equations 3 Years On: Building a Stronger Foundation. , 2016, Circulation.
[21] E. Boerwinkle,et al. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. , 2016, The New England journal of medicine.
[22] Inês Barroso,et al. Prospective functional classification of all possible missense variants in PPARG , 2016, Nature Genetics.
[23] Joseph Loscalzo,et al. Precision medicine in cardiology , 2016, Nature Reviews Cardiology.
[24] M. Perez,et al. Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement From the American Heart Association , 2016, Circulation. Cardiovascular genetics.
[25] Michael P Snyder,et al. Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro. , 2016, Cell stem cell.
[26] D. Roden,et al. Phenome-Wide Association Studies as a Tool to Advance Precision Medicine. , 2016, Annual review of genomics and human genetics.
[27] Tom Michoel,et al. Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases , 2016, Science.
[28] Stephanie Devaney,et al. A Survey of U.S Adults’ Opinions about Conduct of a Nationwide Precision Medicine Initiative® Cohort Study of Genes and Environment , 2016, PloS one.
[29] Samantha A. Adams,et al. Precision medicine: opportunities, possibilities, and challenges for patients and providers , 2016, J. Am. Medical Informatics Assoc..
[30] Brian J. Bennett,et al. Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment A Scientific Statement From the American Heart Association , 2016, Circulation. Cardiovascular genetics.
[31] J. Rumsfeld,et al. Big data analytics to improve cardiovascular care: promise and challenges , 2016, Nature Reviews Cardiology.
[32] D. Gudbjartsson,et al. Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease. , 2016, The New England journal of medicine.
[33] Alexander E. Lopez,et al. Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease. , 2016, The New England journal of medicine.
[34] W. Riley,et al. Precision Public Health for the Era of Precision Medicine. , 2016, American journal of preventive medicine.
[35] Mary Brophy,et al. Million Veteran Program: A mega-biobank to study genetic influences on health and disease. , 2016, Journal of clinical epidemiology.
[36] S. Kardia,et al. Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing , 2016, Healthcare.
[37] M. Hurles,et al. Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research , 2015, European Journal of Human Genetics.
[38] Exome sequencing identifies rare LDLR and APOA 5 alleles conferring risk for myocardial infarction , 2016 .
[40] Rajiv,et al. Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. , 2016, The New England journal of medicine.
[41] A. Trepanier,et al. Comparison of Informed Consent Preferences for Multiplex Genetic Carrier Screening among a Diverse Population , 2016, Journal of Genetic Counseling.
[42] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[43] Yu-Fang Jin,et al. Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association , 2015, Circulation.
[44] D. Sargent,et al. Genotype-based clinical trials in cardiovascular disease , 2015, Nature Reviews Cardiology.
[45] Donald M Bers,et al. Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy. , 2015, Cell stem cell.
[46] Teresa A. Webster,et al. Genotyping Informatics and Quality Control for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort , 2015, Genetics.
[47] David R. Williams,et al. Calling for a bold new vision of health disparities intervention research. , 2015, American journal of public health.
[48] W. Chung,et al. Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility , 2014, Genetics in Medicine.
[49] Jun S. Liu,et al. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.
[50] C. Newgard,et al. Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease. , 2015, Circulation. Cardiovascular genetics.
[51] Thomas May. On the Justifiability of ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing , 2015, Journal of Law, Medicine & Ethics.
[52] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[53] A. Barabasi,et al. Uncovering disease-disease relationships through the incomplete interactome , 2015, Science.
[54] John W McEvoy,et al. An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. , 2015, Annals of internal medicine.
[55] Terri Voepel-Lewis,et al. Digital multimedia: a new approach for informed consent? , 2015, JAMA.
[56] M. Fornage,et al. Basic concepts and potential applications of genetics and genomics for cardiovascular and stroke clinicians: a scientific statement from the American Heart Association. , 2015, Circulation. Cardiovascular genetics.
[57] Eric S. Lander,et al. Systematic Cell-Based Phenotyping of Missense Alleles Empowers Rare Variant Association Studies: A Case for LDLR and Myocardial Infarction , 2015, PLoS genetics.
[58] Andrew D. Johnson,et al. Multiple rare alleles at LDLR and APOA5 confer risk for early-onset myocardial infarction , 2014, Nature.
[59] John Spertus,et al. Inactivating mutations in NPC1L1 and protection from coronary heart disease. , 2014, The New England journal of medicine.
[60] Pierre Fontanillas,et al. Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes , 2014, Proceedings of the National Academy of Sciences.
[61] Michelle Dunn,et al. The National Institutes of Health's Big Data to Knowledge (BD2K) initiative: capitalizing on biomedical big data , 2014, J. Am. Medical Informatics Assoc..
[62] B. Nordestgaard,et al. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. , 2014, The New England journal of medicine.
[63] He Zhang,et al. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. , 2014, The New England journal of medicine.
[64] Susan E. Sheridan,et al. Patient-powered research networks aim to improve patient care and health research. , 2014, Health affairs.
[65] Richard Platt,et al. Four health data networks illustrate the potential for a shared national multipurpose big-data network. , 2014, Health affairs.
[66] Jennifer G. Robinson,et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.
[67] He Zhang,et al. Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk , 2014, Nature Genetics.
[68] Anne Tybjærg-Hansen,et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease , 2014, Nature Genetics.
[69] Jennifer G. Robinson,et al. Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. , 2014, American journal of human genetics.
[70] N. Eriksson,et al. A randomized trial of genotype-guided dosing of warfarin. , 2013, The New England journal of medicine.
[71] Melissa A. Basford,et al. Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data , 2013, Nature Biotechnology.
[72] M. Drazner,et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[73] Tanya M. Teslovich,et al. Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.
[74] Marc S. Williams,et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.
[75] Melissa A. Basford,et al. The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future , 2013, Genetics in Medicine.
[76] Chad A. Cowan,et al. Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. , 2013, Cell stem cell.
[77] G. Omenn,et al. Evolution of Translational Omics: Lessons Learned and the Path Forward , 2013 .
[78] Melissa A. Basford,et al. Genome- and Phenome-Wide Analyses of Cardiac Conduction Identifies Markers of Arrhythmia Risk , 2013, Circulation.
[79] P. Douglas,et al. A Blood-Based Gene Expression Test for Obstructive Coronary Artery Disease Tested in Symptomatic Nondiabetic Patients Referred for Myocardial Perfusion Imaging The COMPASS Study , 2013, Circulation. Cardiovascular genetics.
[80] Kevin Kim,et al. A TALEN genome-editing system for generating human stem cell-based disease models. , 2013, Cell stem cell.
[81] Gordon Keller,et al. Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics , 2013, The Journal of general physiology.
[82] N. Norton,et al. Return of Genetic Results in the Familial Dilated Cardiomyopathy Research Project , 2013, Journal of Genetic Counseling.
[83] P. Ridker,et al. Kinesin-Like Protein 6 (KIF6) Polymorphism and the Efficacy of Rosuvastatin in Primary Prevention , 2011, Circulation. Cardiovascular genetics.
[84] R. Collins,et al. No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study. , 2011, Journal of the American College of Cardiology.
[85] Thomas J. Wang,et al. Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction , 2011, Circulation.
[86] Szilard Voros,et al. Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients , 2011, BMC Medical Genomics.
[87] Zahi A Fayad,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.
[88] Zahi A Fayad,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Journal of the American College of Cardiology.
[89] Jonathan C. Cohen,et al. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. , 2010, The New England journal of medicine.
[90] Alexander F. Wilson,et al. Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies. , 2010, Journal of the American College of Cardiology.
[91] Szilard Voros,et al. Multicenter Validation of the Diagnostic Accuracy of a Blood-Based Gene Expression Test for Assessing Obstructive Coronary Artery Disease in Nondiabetic Patients , 2010, Annals of Internal Medicine.
[92] Olle Melander,et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus , 2010, Nature.
[93] J. Catanese,et al. KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[94] Tanya M. Teslovich,et al. Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.
[95] B. Akolkar,et al. Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium , 2010, Clinical trials.
[96] Teri A Manolio,et al. Genomewide association studies and assessment of the risk of disease. , 2010, The New England journal of medicine.
[97] James Yee,et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. , 2010, The New England journal of medicine.
[98] Heather Skirton,et al. Genetic education and the challenge of genomic medicine: development of core competences to support preparation of health professionals in Europe , 2010, European Journal of Human Genetics.
[99] M. Sabatine,et al. Effect of pravastatin therapy on coronary events in carriers of the KIF6 719Arg allele from the cholesterol and recurrent events trial. , 2010, The American journal of cardiology.
[100] Marylyn D. Ritchie,et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations , 2010, Bioinform..
[101] Jeffrey L. Anderson,et al. ACCF / AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults , 2010 .
[102] A. Barabasi,et al. Network medicine : a network-based approach to human disease , 2010 .
[103] J. Ioannidis,et al. Assessment of claims of improved prediction beyond the Framingham risk score. , 2009, JAMA.
[104] I. Tikhonova,et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing , 2009, Proceedings of the National Academy of Sciences.
[105] Emily H Turner,et al. Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes , 2009, Nature.
[106] R. Collins,et al. Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.
[107] Gail Geller,et al. Public Expectations for Return of Results from Large-Cohort Genetic Research , 2008, The American journal of bioethics : AJOB.
[108] Geoffrey S Ginsburg,et al. Correlation of Peripheral-Blood Gene Expression With the Extent of Coronary Artery Stenosis , 2008, Circulation. Cardiovascular genetics.
[109] A. Fiester. Justifying a Presumption of Restraint in Animal Biotechnology Research , 2008, The American journal of bioethics : AJOB.
[110] R. Collins,et al. SLCO1B1 variants and statin-induced myopathy--a genomewide study. , 2008, The New England journal of medicine.
[111] R. Collins,et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.
[112] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[113] P. Ridker,et al. A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study. , 2008, Journal of the American College of Cardiology.
[114] Marc A Pfeffer,et al. Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. , 2008, Journal of the American College of Cardiology.
[115] M. Sabatine,et al. Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. , 2008, Journal of the American College of Cardiology.
[116] Dolores Corella,et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.
[117] T. Pawson,et al. Network medicine , 2008, FEBS letters.
[118] H. Greely. The uneasy ethical and legal underpinnings of large-scale genomic biobanks. , 2007, Annual review of genomics and human genetics.
[119] C. Gieger,et al. Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.
[120] B. Knoppers,et al. Trends in ethical and legal frameworks for the use of human biobanks , 2007, European Respiratory Journal.
[121] A. Gylfason,et al. A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction , 2007, Science.
[122] Marcia M. Nizzari,et al. Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.
[123] Jonathan C. Cohen,et al. A Common Allele on Chromosome 9 Associated with Coronary Heart Disease , 2007, Science.
[124] N. Cook. Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.
[125] Christian Gieger,et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization , 2006, Nature Genetics.
[126] T. Klingler,et al. Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[127] John F. Hurdle,et al. Measuring diagnoses: ICD code accuracy. , 2005, Health services research.
[128] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[129] M. Olivier. A haplotype map of the human genome. , 2003, Nature.
[130] M. Olivier. A haplotype map of the human genome , 2003, Nature.
[131] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[132] D. Hosmer,et al. A review of goodness of fit statistics for use in the development of logistic regression models. , 1982, American journal of epidemiology.